Business
Total Voting Rights
Total Voting Rights.
About this update from Cellbxhealth Plc
[{"type":"text","content":"\n \nRNS Number : 6852U Angle PLC 26 October 2017 \n\n\n\n\n\nFor immediate release\n\n\n26 October 2017\n\n\n\n\n \nANGLE plc (\"the Company\")\n \nTotal Voting Rights\n \n \nANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, announces that, following the announcement of 12 October 2017, 7,481,570 New Ordinary Shares have been issued pursuant to the Further Subscription. Following completion of the Admission of the Further Subscription Shares, the total number of Ordinary Shares in issue is 82,297,344.\n \nThe figure of 82,297,344 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.\n \nCapitalised terms not otherwise defined in this announcement shall have the same meaning ascribed to such terms in the announcement entitled \"Proposed Further Subscription For £2.8 Million\" released on 12 October 2017 unless the context requires otherwise.\n \n \nFor further information ANGLE:\n \n\n\n\n\nANGLE plc\n\n\n+44 (0) 1483 343434\n\n\n\n\nAndrew Newland, Chief Executive\nIan Griffiths, Finance Director\n \n\n\n\n\n\n\n\nfinnCap Ltd (NOMAD and Joint Broker)\nCorporate Finance - Adrian Hargrave, Simon Hicks, Kate Bannatyne\nCorporate Broking - Alice Lane, Nikita Jain \n \n\n\n+44 (0) 207 220 0500\n\n\n\n\nWG Partners (Joint Broker)\nNigel Barnes, Nigel Birks, Andrew Craig, Chris Lee \n \n\n\n+44 (0) 203 705 9330\n \n\n\n\n\nFTI Consulting\nSimon Conway, Mo Noonan, Stephanie Cuthbert\nKimberly Ha (US) \n\n\n \n+44 (0) 203 727 1000\n+1 212 850 5612\n\n\n\n\n \n \n \nNotes for editors\n \nAbout ANGLE plc www.angleplc.com \n \nANGLE is a world-leading liquid biopsy company commercialising a disruptive platform technology that can capture cells circulating in blood, such as cancer cells, even when they are as rare in number as one cell in one billion blood cells, and harvest the cells for analysis.\n \nANGLE's cell separation technology is called the ParsortixTM system and it enables a liquid biopsy (simple blood test) to be used to provide the cells of interest. Parsortix is the subject...